2002
DOI: 10.1006/mthe.2002.0606
|View full text |Cite
|
Sign up to set email alerts
|

Antitumor Activity and Bystander Effect of Adenovirally Delivered Tissue Inhibitor of Metalloproteinases-3

Abstract: We have studied the effect of a newly identified tumor suppressor tissue inhibitor of metalloproteinases- 3 (TIMP-3) on the growth of human melanoma and squamous-cell carcinoma (SCC). Adenoviral delivery of the TIMP-3 gene to human melanoma (A2058) and SCC (UT-SCC-7) cells ex vivo inhibited tumorigenesis after subcutaneous (s.c.) injection of the infected cells into SCID/SCID mice. Three daily consecutive intratumoral injections of 1.4x10(9) plaque-forming units (pfu) of TIMP-3 adenovirus (RAdTIMP-3) inhibited… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
65
1

Year Published

2002
2002
2009
2009

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 72 publications
(75 citation statements)
references
References 37 publications
9
65
1
Order By: Relevance
“…48 Our microarray data also indicated a 1.6-fold up-regulation of TIMP-3 expression in the tissue surrounding the tumor. The tumor-suppressive activity of this proapoptotic agent has been repeatedly demonstrated [49][50][51] and its up-regulation in host tissue neighboring the tumor was also observed in breast carcinomaassociated fibroblasts, 52 stromal cells surrounding squamous-cell carcinoma and LN metastases. 53 Thus, TIMP-3 inducible expression in the tumor microenvironment may be an example of a stromal defensive effect against tumor development.…”
Section: Discussionmentioning
confidence: 99%
“…48 Our microarray data also indicated a 1.6-fold up-regulation of TIMP-3 expression in the tissue surrounding the tumor. The tumor-suppressive activity of this proapoptotic agent has been repeatedly demonstrated [49][50][51] and its up-regulation in host tissue neighboring the tumor was also observed in breast carcinomaassociated fibroblasts, 52 stromal cells surrounding squamous-cell carcinoma and LN metastases. 53 Thus, TIMP-3 inducible expression in the tumor microenvironment may be an example of a stromal defensive effect against tumor development.…”
Section: Discussionmentioning
confidence: 99%
“…5b) but was not evident in the nontumorigenic keratinocyte cell line HaCaT 19 treated with TNF-(20 ng/ml), TGF-␤1 (5 ng/ml) or IFN-␥ (100 U/ml) for 24 hr (data not shown). In addition, no expression of MMP-19 mRNA was detected in A5 cells, a rastransformed HaCaT cell-derived cell line that forms benign tumors 20 or in cutaneous SCC metastasis-derived UT-SCC-7 cells, which form SCCs in SCID mice 21 (data not shown). Although immortalized HaCaT cells are nontumorigenic, their MMP expression profile clearly differs from that of primary keratinocytes, e.g., MMP-12 and MMP-13, which are upregulated in the course of epithelial transformation and expressed by HaCaT cells but not by primary keratinocytes.…”
Section: Northern and Western Analyses Of Keratinocytesmentioning
confidence: 93%
“…The UT-SCC-7 cell line, which forms SCCs in SCID mice, 21 was established from metastasis of a cutaneous SCC at the time of operation in the Turku University Central Hospital. 22 Cell lines were cultured in DMEM supplemented with 6 mM glutamine, nonessential amino acids and 10% FCS.…”
Section: Cell Culturesmentioning
confidence: 99%
“…This suggests that TIMP-3 expressed by the AdTIMP-3 tumor cells was having a bystander effect on the untransduced tumor cells, illustrating that in the case of gene transfer systems, secreted proteins such as the TIMPs are advantageous as antiangiogenesis/anticancer agents. 139 The proapoptotic effects of TIMP-3 may mean that as well as acting as an antiangiogenic factor, this inhibitor could reduce tumor size by promoting tumor cell apoptosis. The potent affinity of TIMP-3 for the ECM means that this inhibitor will maintain local distribution, meaning higher concentrations of TIMP-3 at the site of the disease.…”
Section: Timps As Potential Antiangiogenic Agentsmentioning
confidence: 99%